Adenoviral vector-based vaccines
    5.
    发明申请
    Adenoviral vector-based vaccines 审中-公开
    基于腺病毒载体的疫苗

    公开(公告)号:US20060286121A1

    公开(公告)日:2006-12-21

    申请号:US11337866

    申请日:2006-01-23

    IPC分类号: A61K39/12 A61K39/395

    摘要: The invention provides a method of inducing an immune response in a mammal. The method comprises administering to the mammal a non-subgroup C adenoviral vector comprising an adenoviral fiber protein having an amino acid sequence comprising about 80% or more identity to an amino acid sequence encoding a subgroup C adenoviral fiber protein. The adenoviral vector further comprises a nucleic acid sequence encoding an antigen which is expressed in the mammal to induce an immune response. The invention further comprises a method of producing an adenoviral vector, and a composition comprising a serotype 41 or a serotype 35 adenoviral vector and a carrier. The invention also provides an adenoviral vector comprising a nucleic acid sequence encoding an adenoviral pIX protein operably linked to a heterologous expression control sequence, as well as a method of enhancing the stability and/or packaging capacity of an adenoviral vector.

    摘要翻译: 本发明提供在哺乳动物中诱导免疫应答的方法。 该方法包括向哺乳动物施用非亚组C腺病毒载体,其包含具有与编码亚组C腺病毒纤维蛋白的氨基酸序列具有约80%或更高同一性的氨基酸序列的腺病毒纤维蛋白。 腺病毒载体还包含编码在哺乳动物中表达以诱导免疫应答的抗原的核酸序列。 本发明还包括产生腺病毒载体的方法和包含血清型41或血清型35腺病毒载体和载体的组合物。 本发明还提供了一种腺病毒载体,其包含编码与异源表达控制序列可操作地连接的腺病毒pIX蛋白的核酸序列,以及增强腺病毒载体的稳定性和/或包装能力的方法。